Search

everythinglearnresearchcommunity

for

Search:↓

Interleukin-2 treatment improved hair growth, sexual function, and reduced fungal infection in a patient with thymoma-related symptoms.

The G allele of IFITM3 rs12252 is linked to more severe COVID-19.

A skin rash after the AstraZeneca COVID-19 vaccine was treated successfully with medication.

MIS-A is a severe complication after COVID-19, mostly in young black males, needing more research and awareness.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

Purpura fulminans can signal underlying autoimmune disorders, not just infections.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

DPCP immunotherapy is effective for alopecia areata, and understanding influencing factors can improve treatment and satisfaction.

hsa-miR-193a-5p may help diagnose and treat alopecia areata.

Dupilumab may help treat alopecia areata without needing high IgE levels.

The girl's condition improved with treatment, showing no new autoimmune diseases and hair regrowth.

New treatments for alopecia areata show promise in improving hair loss outcomes.

Rituximab can cause skin issues, but baricitinib may help improve them.

Early diagnosis and teamwork are crucial for managing ILVASC effectively.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Retinol may affect immune responses in people with frequent skin boils.

Trichodysplasia spinulosa is a rare skin disease in immunocompromised patients caused by a specific virus targeting hair follicle cells.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

Benign follicular mucinosis involves immune cells attacking hair follicles.

Ixekizumab has known and some unexpected side effects.

Autoimmune myopathy may be linked to hair loss and skin depigmentation.

Alopecia areata patients have higher IgE and IL-13 levels, suggesting immune involvement.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

Blocking LFA-1 prevents hair loss in mice.

Regulatory T cells protect hair follicle stem cells by maintaining immune privilege in the skin.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.